Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dillon

Showing results (531-540 of 576) with videos related to

Pageof 58
Sort By:
JBMR Plus|November 11, 2025
Identification of novel collagen breakdown products by human osteoclasts in vitro and in vivoBrendan P Norman, Jane P Dillon, Sahem M Alkharabsheh, et al.
Stroke|November 29, 2008
Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation strokeGregory V Goldmakher, Erica C S Camargo, Karen L Furie, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
AJNR. American Journal of Neuroradiology|March 11, 2017
Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid PathologyA A Thaker, B D Weinberg, W P Dillon, et al.
Journal of Neurosurgery|October 10, 1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapyL L Wald, S J Nelson, M R Day, et al.
The Journal of Experimental Medicine|September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defenseLance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2019
ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1Justin P Ingram, Roshan J Thapa, Amanda Fisher, et al.
Annals of Neurology|September 24, 2017
Polygenic hazard scores in preclinical Alzheimer diseaseChin Hong Tan, Bradley T Hyman, Jacinth J X Tan, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody-Drug ConjugatesAlexei S Karpov, Tinya Abrams, Suzanna Clark, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsPaul A Barsanti, Yue Pan, Yipin Lu, et al.
Pageof 58

Showing results (531-540 of 576) with videos related to

Sort By:
Pageof 58
JBMR Plus|November 11, 2025
Identification of novel collagen breakdown products by human osteoclasts in vitro and in vivoBrendan P Norman, Jane P Dillon, Sahem M Alkharabsheh, et al.
Stroke|November 29, 2008
Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation strokeGregory V Goldmakher, Erica C S Camargo, Karen L Furie, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
AJNR. American Journal of Neuroradiology|March 11, 2017
Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid PathologyA A Thaker, B D Weinberg, W P Dillon, et al.
Journal of Neurosurgery|October 10, 1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapyL L Wald, S J Nelson, M R Day, et al.
The Journal of Experimental Medicine|September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defenseLance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2019
ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1Justin P Ingram, Roshan J Thapa, Amanda Fisher, et al.
Annals of Neurology|September 24, 2017
Polygenic hazard scores in preclinical Alzheimer diseaseChin Hong Tan, Bradley T Hyman, Jacinth J X Tan, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody-Drug ConjugatesAlexei S Karpov, Tinya Abrams, Suzanna Clark, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsPaul A Barsanti, Yue Pan, Yipin Lu, et al.
Pageof 58